We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
The Case for Combined-Modality Therapy for Limited-Stage Hodgkin's Disease.
- Authors
Hill-Kayser, Christine E.; Plastaras, John P.; Tochner, Zelig; Glatstein, Eli
- Abstract
The authors discuss a study by R. M. Meyer and colleagues, which investigated differences in outcome when patients with limited-stage Hodgkin's Disease (HD) were randomized to receive only chemotherapy with doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) or treatment that included subtotal lymph node irradiation (STLNI). They explore this study by comparing it with the findings of other studies and opine that nature of STLNI in their discussion was outdated.
- Subjects
COMBINED modality therapy; ANTINEOPLASTIC agents; RADIOTHERAPY; HODGKIN'S disease; DOSE-response relationship (Radiation); LYMPH nodes; HEALTH outcome assessment; TREATMENT effectiveness
- Publication
Oncologist, 2012, Vol 17, Issue 8, p1006
- ISSN
1083-7159
- Publication type
Editorial
- DOI
10.1634/theoncologist.2012-0148